Gynecologic Tumors

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2017-02-23
Clinical Trial Update: Phase I Trial of Oral Metronomic Topotecan and Oral Pazopanib to Treat Recurrent/Persistent Gynecologic Tumors [Phase 1]
This Phase I trial evaluated oral metronomic topotecan in combination with pazopanib for recurrent/persistent gynecologic tumors; the study …